Ribociclib in advanced breast cancer: Survival advantages, but also severe side effects - EurekAlert

Ribociclib in advanced breast cancer: Survival advantages, but also severe side effects  EurekAlertStudy indicates longer overall survival of postmenopausal women. However, there is a higher frequency of severe diseases of blood and lymphatic system.